UKLTH Funds R&D of Diabetes Monitoring Device

ArabNet Team, May 30 2017

UK Lebanon Tech Hub (UKLTH) announced that it will fund the Research and Development (R&D) of ediamond (Electromagnetic Diabetes Monitoring Device) - a non-invasive blood glucose-monitoring device.

The technology is being developed by the Maroun Semaan Faculty of Engineering and Architecture and the Faculty of Medicine at the American University of Beirut (AUB). It consists of a wearable device that will enable diabetic patients to check their glucose levels without needing to come into contact with their blood stream, i.e. through conventional methods such as repeatedly pricking their finger with a needle throughout the day.

The partnership was agreed on at a formal signing ceremony on Wednesday 17th May, which was attended by H.E. Nicolas Sehnaoui, Chairman of the Board of the UKLTH, Dr. Fadlo R. Khuri, President of AUB and Dr. Mohamed Harajli, Provost of AUB, in addition to AUB Deans of Medicine and Engineering and Architecture and senior executives. 

“With 15 per cent of the world’s population suffering from diabetes, this device could make could make a profound difference to the lives of hundreds of millions of people,” according to Sehnaoui.

UKLTH’s announcement not only reflects its commitment to supporting research projects, but also comes in a day and age where Arab countries suffer from the lack of investment in R&D. According to the UNESCO Institute of Statistics, Arab countries only allocated a maximum of 0.7% of their GDP to R&D, whilst EU countries allocated up to 3.2 % and Japan allocated 3.6%.

Moreover, the collaboration between the UKLTH and AUB is aligned with the organization’s support to the recently set-up International Research Centre (IRC), whose mission is to boost investment in R&D in Lebanon and the MENA, by developing links between universities and entrepreneurs. Or, last February UKLTH had launched IRC and announced the first Agritech project with the support and funding of the British Embassy in Beirut.

 

 

 

 

 

 

 

Comments   

Catch up on what you've missed